XML 46 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2022
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Fair Value and Balance Sheet Locations

The following tables provide information about the fair values of our derivative financial instruments as of the respective balance sheet dates:

 

 

March 31, 2022

 

 

 

Asset Derivatives

 

(In thousands)

 

Balance Sheet Location

 

Fair Value

 

Derivatives qualifying as cash flow hedges:

 

 

 

 

 

Foreign exchange contracts

 

Prepaid expenses and other current assets

 

$

100

 

Total derivatives

 

 

 

$

100

 

 

 

 

December 31, 2021

 

 

 

Asset Derivatives

 

(In thousands)

 

Balance Sheet Location

 

Fair Value

 

Derivatives qualifying as cash flow hedges:

 

 

 

 

 

Foreign exchange contracts

 

Prepaid expenses and other current assets

 

$

352

 

Total derivatives

 

 

 

$

352

 

Derivatives Instruments Designated as Cash Flow Hedges

The following tables show the impact of derivative instruments designated as cash flow hedges on the consolidated statements of operations and the consolidated statements of comprehensive income (loss):

 

 

Amount of Gain (Loss) Recognized
in OCI

 

 

 

 

Amount of Gain (Loss) Reclassified from AOCI into Income

 

(In thousands)

 

Three Months
Ended
March 31, 2022

 

 

Location of Gain (Loss) Reclassified
from AOCI into Income

 

Three Months
Ended
March 31, 2022

 

Foreign exchange contracts

 

$

(148

)

 

Cost of Revenue

 

$

37

 

 

 

 

 

 

Selling, general and
   administrative expenses

 

 

24

 

 

 

 

 

 

Research and development

 

$

43

 

 

 

 

Amount of Gain (Loss) Recognized
in OCI

 

 

 

 

Amount of Gain (Loss) Reclassified from AOCI into Income

 

(In thousands)

 

Three Months
Ended
March 31, 2021

 

 

Location of Gain (Loss) Reclassified
from AOCI into Income

 

Three Months
Ended
March 31, 2021

 

Foreign exchange contracts

 

$

175

 

 

Cost of Revenue

 

$

321

 

 

 

 

 

 

Selling, general and
   administrative expenses

 

 

184

 

 

 

 

 

 

Research and development

 

$

351